{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "TWD", "exchange": "TWO", "shortName": "TWi Biotech", "longName": "TWi Biotechnology, Inc.", "messageBoardId": "finmb_257194472", "market": "tw_market", "marketState": "POSTPOST", "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.1, "sharesOutstanding": 67834000, "bookValue": 3.559, "fiftyDayAverage": 21.343, "fiftyDayAverageChange": -2.0430012, "fiftyDayAverageChangePercent": -0.0957223, "twoHundredDayAverage": 15.56825, "tradeable": false, "cryptoTradeable": false, "exchangeTimezoneName": "Asia/Taipei", "exchangeTimezoneShortName": "CST", "gmtOffSetMilliseconds": 28800000, "esgPopulated": false, "regularMarketChangePercent": -0.77121603, "regularMarketPrice": 19.3, "regularMarketChange": -0.15000153, "regularMarketTime": 1684133919, "regularMarketDayHigh": 19.75, "regularMarketDayRange": "19.2 - 19.75", "regularMarketDayLow": 19.2, "regularMarketVolume": 50510, "regularMarketPreviousClose": 19.45, "bid": 19.2, "ask": 19.4, "bidSize": 0, "askSize": 0, "fullExchangeName": "Taipei Exchange", "financialCurrency": "TWD", "regularMarketOpen": 19.35, "averageDailyVolume3Month": 480137, "averageDailyVolume10Day": 76293, "fiftyTwoWeekLowChange": 8.749999, "fiftyTwoWeekLowChangePercent": 0.8293838, "fiftyTwoWeekRange": "10.55 - 26.0", "fiftyTwoWeekHighChange": -6.700001, "fiftyTwoWeekHighChangePercent": -0.25769234, "fiftyTwoWeekLow": 10.55, "fiftyTwoWeekHigh": 26.0, "twoHundredDayAverageChange": 3.7317495, "twoHundredDayAverageChangePercent": 0.23970257, "marketCap": 1315927936, "priceToBook": 5.4228716, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "firstTradeDateMilliseconds": 1482800400000, "priceHint": 2, "symbol": "6610.TWO"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "No. 41, Lane 221", "address2": "8th Floor Kang Chien Road Neihu District", "city": "Taipei", "zip": "11494", "country": "Taiwan", "phone": "886 2 2657 1788", "fax": "886 2 2657 0270", "website": "https://www.twibiotech.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "TWi Biotechnology, Inc., a clinical-stage biopharmaceutical company, develops and sells drugs for innate immunity-related diseases in Taiwan. The company provides AC-203, which is in Phase 2 clinical trial for various indications, including epidermolysis bullosa simplex, bullous pemphigoid, and epidermolysis bullosa; AC-701 that is in Phase 2 clinical trial to treat various inflammatory skin diseases; and AC- 1101, which is in Phase 1 trial for the treatment of vitiligo, as well as in preclinical stage for the treatment of atopic dermatitis. It has a strategic partnership with Hongkong Winhealth Pharma Group granting Winhealth Pharma exclusive right to develop and commercialize rare disease asset AC-203 for various indications, including hereditary epidermolysis bullosa, bullous pemphigoid, and other skin diseases in Mainland China, Hong Kong, and Macao. The company was founded in 2010 and is based in Taipei, Taiwan.", "fullTimeEmployees": 18, "companyOfficers": [{"maxAge": 1, "name": "Ms. Chloe  Weng", "title": "Pres", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Chih-Ming  Chen Ph.D.", "title": "Founder", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Guang-Wei  Lu Ph.D.", "title": "Sr. VP of R&D", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}